{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:08:43Z","timestamp":1789056523219,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,9]]},"DOI":"10.7759\/cureus.78797","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T07:23:26Z","timestamp":1739172206000},"source":"Crossref","is-referenced-by-count":1,"title":["A Review of the Hematological Picture of Severe COVID-19 Infection"],"prefix":"10.7759","author":[{"given":"Dominga","family":"Amoroso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Bongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Copponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Di Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Ippoliti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Morello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Hematological parameters and their predictive value for assessing disease severity in laboratory-confirmed COVID-19 patients: a retrospective study","volume":"13","author":"Awoke MA","year":"2023","unstructured":"Awoke MA, Adane A, Assefa B, Getawa S, Legese GL, Yimer M. Hematological parameters and their predictive value for assessing disease severity in laboratory-confirmed COVID-19 patients: a retrospective study. Am J Blood Res. 2023, 13:117-29.","journal-title":"Am J Blood Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5005\/japi-11001-0200","article-title":"Hematological and other laboratory parameter changes in COVID-19 patients","volume":"71","author":"Khatib Y","year":"2023","unstructured":"Khatib Y, Samele R, Chaudhari J, Khare M, Gupte P, Sable Y, Shah V. Hematological and other laboratory parameter changes in COVID-19 patients. J Assoc Physicians India. 2023, 71:11-2. 10.5005\/japi-11001-0200","journal-title":"J Assoc Physicians India"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2021.12.001","article-title":"Hematological changes in SARS-COV-2 positive patients","volume":"44","author":"Urbano M","year":"2022","unstructured":"Urbano M, Costa E, Geraldes C. Hematological changes in SARS-COV-2 positive patients. Hematol Transfus Cell Ther. 2022, 44:218-24. 10.1016\/j.htct.2021.12.001","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_2453_21","article-title":"Routine hematology parameters in COVID-19: a predictor of disease severity and mortality","volume":"11","author":"Awale RB","year":"2022","unstructured":"Awale RB, Singh A, Mishra P, et al.. Routine hematology parameters in COVID-19: a predictor of disease severity and mortality. J Family Med Prim Care. 2022, 11:3423-9. 10.4103\/jfmpc.jfmpc_2453_21","journal-title":"J Family Med Prim Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108781","article-title":"Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19","volume":"109","author":"Ben Jemaa A","year":"2022","unstructured":"Ben Jemaa A, Salhi N, Ben Othmen M, et al.. Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19. Int Immunopharmacol. 2022, 109:108781. 10.1016\/j.intimp.2022.108781","journal-title":"Int Immunopharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06899-7","article-title":"Characteristics of peripheral white blood cells in COVID-19 patients revealed by a retrospective cohort study","volume":"21","author":"Tong X","year":"2021","unstructured":"Tong X, Cheng A, Yuan X, et al.. Characteristics of peripheral white blood cells in COVID-19 patients revealed by a retrospective cohort study. BMC Infect Dis. 2021, 21:1236. 10.1186\/s12879-021-06899-7","journal-title":"BMC Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24046","article-title":"Association of lymphocyte subsets with mortality in severe COVID-19 pneumonia patients","volume":"35","author":"Ashrafi F","year":"2021","unstructured":"Ashrafi F, Nematollahi P, Salmasi M, Hedayat A, Amra B. Association of lymphocyte subsets with mortality in severe COVID-19 pneumonia patients. J Clin Lab Anal. 2021, 35:e24046. 10.1002\/jcla.24046","journal-title":"J Clin Lab Anal"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID- 19): a meta-analysis","volume":"58","author":"Henry BM","year":"2020","unstructured":"Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID- 19): a meta-analysis. Clin Chem Lab Med. 2020, 58:1021-8. 10.1515\/cclm-2020-0369","journal-title":"Clin Chem Lab Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238160","article-title":"Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: a meta-analysis of 6320 patients","volume":"15","author":"Elshazli RM","year":"2020","unstructured":"Elshazli RM, Toraih EA, Elgaml A, et al.. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: a meta-analysis of 6320 patients. PLoS One. 2020, 15:e0238160. 10.1371\/journal.pone.0238160","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.15331","article-title":"Can we predict the severity of coronavirus disease 2019 with a routine blood test?","volume":"130","author":"Zeng F","year":"2020","unstructured":"Zeng F, Li L, Zeng J, Deng Y, Huang H, Chen B, Deng G. Can we predict the severity of coronavirus disease 2019 with a routine blood test?. Pol Arch Intern Med. 2020, 130:400-6. 10.20452\/pamw.15331","journal-title":"Pol Arch Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11581","article-title":"Hematological changes in patients with COVID\u201119 (review)","volume":"22","author":"Ye J","year":"2020","unstructured":"Ye J, Jiao Y, Zhang Y, Li Z, Zeng X, Deng H, Yang M. Hematological changes in patients with COVID\u201119 (review). Mol Med Rep. 2020, 22:4485-91. 10.3892\/mmr.2020.11581","journal-title":"Mol Med Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24064","article-title":"Hematological changes associated with COVID-19 infection","volume":"36","author":"Al-Saadi EA","year":"2022","unstructured":"Al-Saadi EA, Abdulnabi MA. Hematological changes associated with COVID-19 infection. J Clin Lab Anal. 2022, 36:e24064. 10.1002\/jcla.24064","journal-title":"J Clin Lab Anal"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2021.030501","article-title":"Complete blood count alterations in COVID-19 patients: a narrative review","volume":"31","author":"Palladino M","year":"2021","unstructured":"Palladino M. Complete blood count alterations in COVID-19 patients: a narrative review. Biochem Med (Zagreb). 2021, 31:030501. 10.11613\/BM.2021.030501","journal-title":"Biochem Med (Zagreb)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12503","article-title":"Verification and quality control of routine hematology analyzers","volume":"38 Suppl 1","author":"Vis JY","year":"2016","unstructured":"Vis JY, Huisman A. Verification and quality control of routine hematology analyzers. Int J Lab Hematol. 2016, 38 Suppl 1:100-9. 10.1111\/ijlh.12503","journal-title":"Int J Lab Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100743","article-title":"The looming storm: blood and cytokines in COVID-19","volume":"46","author":"Kaur S","year":"2021","unstructured":"Kaur S, Bansal R, Kollimuttathuillam S, Gowda AM, Singh B, Mehta D, Maroules M. The looming storm: blood and cytokines in COVID-19. Blood Rev. 2021, 46:100743. 10.1016\/j.blre.2020.100743","journal-title":"Blood Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.39.3.6836","article-title":"Hematological findings in COVID-19 and their correlation with severity of disease","volume":"39","author":"Mahmood N","year":"2023","unstructured":"Mahmood N, Riaz Z, Sattar A, Kiran M. Hematological findings in COVID-19 and their correlation with severity of disease. Pak J Med Sci. 2023, 39:795-8. 10.12669\/pjms.39.3.6836","journal-title":"Pak J Med Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.22092\/ARI.2022.358363.2208","article-title":"Hematological parameters in COVID-19 patients: association with severity of the disease","volume":"77","author":"Abdulla AA","year":"2022","unstructured":"Abdulla AA, Abdulaali Abed T, Fadhel Abbas Awadh E. Hematological parameters in COVID-19 patients: association with severity of the disease. Arch Razi Inst. 2022, 77:2415-21. 10.22092\/ARI.2022.358363.2208","journal-title":"Arch Razi Inst"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2023.046","article-title":"Preliminary study of sCD14 and sCD163 as predictors of disease severity and ICU admission in COVID-19: relation to hematological parameters, blood morphological changes and inflammatory biomarkers","volume":"15","author":"Attia H","year":"2023","unstructured":"Attia H, El Nagdy M, Abdel Halim RM. Preliminary study of sCD14 and sCD163 as predictors of disease severity and ICU admission in COVID-19: relation to hematological parameters, blood morphological changes and inflammatory biomarkers. Mediterr J Hematol Infect Dis. 2023, 15:e2023046. 10.4084\/MJHID.2023.046","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23809","article-title":"Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan's experience","volume":"35","author":"Waris A","year":"2021","unstructured":"Waris A, Din M, Khalid A, et al.. Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan's experience. J Clin Lab Anal. 2021, 35:e23809. 10.1002\/jcla.23809","journal-title":"J Clin Lab Anal"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin C","year":"2020","unstructured":"Qin C, Zhou L, Hu Z, et al.. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020, 71:762-8. 10.1093\/cid\/ciaa248","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30217-9","article-title":"Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study","volume":"7","author":"Liao D","year":"2020","unstructured":"Liao D, Zhou F, Luo L, et al.. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol. 2020, 7:e671-8. 10.1016\/S2352-3026(20)30217-9","journal-title":"Lancet Haematol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-021-01710-w","article-title":"Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study","volume":"49","author":"Eijmael M","year":"2021","unstructured":"Eijmael M, Janssens N, le Cessie S, van Dooren Y, Koster T, Karim F. Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study. Infection. 2021, 49:1325-9. 10.1007\/s15010-021-01710-w","journal-title":"Infection"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000824","article-title":"Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study","volume":"133","author":"Deng Y","year":"2020","unstructured":"Deng Y, Liu W, Liu K, et al.. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020, 133:1261-7. 10.1097\/CM9.0000000000000824","journal-title":"Chin Med J (Engl)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4314\/ejhs.v33i2.3","article-title":"Hematological and biochemical parameters at admission as predictors for mortality in patients with moderate to severe COVID-19","volume":"33","author":"Pertiwi D","year":"2023","unstructured":"Pertiwi D, Nisa M, Aulia AP, Rahayu. Hematological and biochemical parameters at admission as predictors for mortality in patients with moderate to severe COVID-19. Ethiop J Health Sci. 2023, 33:193-202. 10.4314\/ejhs.v33i2.3","journal-title":"Ethiop J Health Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77698-4","article-title":"Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients","volume":"10","author":"Bellan M","year":"2020","unstructured":"Bellan M, Patti G, Hayden E, et al.. Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients. Sci Rep. 2020, 10:20731. 10.1038\/s41598-020-77698-4","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.12879","article-title":"Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report","volume":"14","author":"Paliogiannis P","year":"2020","unstructured":"Paliogiannis P, Zinellu A, Scano V, et al.. Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report. J Infect Dev Ctries. 2020, 14:685-90. 10.3855\/jidc.12879","journal-title":"J Infect Dev Ctries"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13040746","article-title":"Serial changes in blood-cell-count-derived and CRP-derived inflammatory indices of COVID-19 patients","volume":"13","author":"Khadzhieva MB","year":"2023","unstructured":"Khadzhieva MB, Gracheva AS, Belopolskaya OB, Chursinova YV, Redkin IV, Pisarev MV, Kuzovlev AN. Serial changes in blood-cell-count-derived and CRP-derived inflammatory indices of COVID-19 patients. Diagnostics (Basel). 2023, 13:10.3390\/diagnostics13040746","journal-title":"Diagnostics (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2497202","article-title":"The neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio as predictors of mortality in older adults hospitalized with COVID-19 in Peru","volume":"2022","author":"Ortega-Rojas S","year":"2022","unstructured":"Ortega-Rojas S, Salazar-Talla L, Romero-Cerd\u00e1n A, Soto-Becerra P, D\u00edaz-V\u00e9lez C, Urrunaga-Pastor D, Magui\u00f1a JL. The neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio as predictors of mortality in older adults hospitalized with COVID-19 in Peru. Dis Markers. 2022, 2022:2497202. 10.1155\/2022\/2497202","journal-title":"Dis Markers"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang X","year":"2020","unstructured":"Yang X, Yu Y, Xu J, et al.. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020, 8:475-81. 10.1016\/S2213-2600(20)30079-5","journal-title":"Lancet Respir Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-022-01926-8","article-title":"Characteristics of lymphocyte subset alterations in COVID-19 patients with different levels of disease severity","volume":"19","author":"Dai W","year":"2022","unstructured":"Dai W, Zhong A, Qiao Q, et al.. Characteristics of lymphocyte subset alterations in COVID-19 patients with different levels of disease severity. Virol J. 2022, 19:192. 10.1186\/s12985-022-01926-8","journal-title":"Virol J"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan WJ","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020, 382:1708-20. 10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23620","article-title":"Expression of eosinophil in peripheral blood of patients with COVID-19 and its clinical significance","volume":"35","author":"Mu T","year":"2021","unstructured":"Mu T, Yi Z, Wang M, et al.. Expression of eosinophil in peripheral blood of patients with COVID-19 and its clinical significance. J Clin Lab Anal. 2021, 35:e23620. 10.1002\/jcla.23620","journal-title":"J Clin Lab Anal"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2021.1877580","article-title":"Low vitamin d status at admission as a risk factor for poor survival in hospitalized patients with COVID-19: an Italian retrospective study","volume":"41","author":"Infante M","year":"2022","unstructured":"Infante M, Buoso A, Pieri M, et al.. Low vitamin d status at admission as a risk factor for poor survival in hospitalized patients with COVID-19: an Italian retrospective study. J Am Nutr Assoc. 2022, 41:250-65. 10.1080\/07315724.2021.1877580","journal-title":"J Am Nutr Assoc"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.119010","article-title":"Monocytes and macrophages in COVID-19: friends and foes","volume":"269","author":"Meidaninikjeh S","year":"2021","unstructured":"Meidaninikjeh S, Sabouni N, Marzouni HZ, Bengar S, Khalili A, Jafari R. Monocytes and macrophages in COVID-19: friends and foes. Life Sci. 2021, 269:119010. 10.1016\/j.lfs.2020.119010","journal-title":"Life Sci"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.560381","article-title":"Increased serum levels of sCD14 and sCD163 indicate a preponderant role for monocytes in COVID-19 immunopathology","volume":"11","author":"G\u00f3mez-Rial J","year":"2020","unstructured":"G\u00f3mez-Rial J, Curr\u00e1s-Tuala MJ, Rivero-Calle I, et al.. Increased serum levels of sCD14 and sCD163 indicate a preponderant role for monocytes in COVID-19 immunopathology. Front Immunol. 2020, 11:560381. 10.3389\/fimmu.2020.560381","journal-title":"Front Immunol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24172","article-title":"Lymphocyte subset counts in COVID-19 patients: a meta-analysis","volume":"97","author":"Huang W","year":"2020","unstructured":"Huang W, Berube J, McNamara M, et al.. Lymphocyte subset counts in COVID-19 patients: a meta-analysis. Cytometry A. 2020, 97:772-6. 10.1002\/cyto.a.24172","journal-title":"Cytometry A"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1807836","article-title":"Immune responses during COVID-19 infection","volume":"9","author":"Melenotte C","year":"2020","unstructured":"Melenotte C, Silvin A, Goubet AG, et al.. Immune responses during COVID-19 infection. Oncoimmunology. 2020, 9:1807836. 10.1080\/2162402X.2020.1807836","journal-title":"Oncoimmunology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202108_26463","article-title":"Alterations in lymphocyte subsets and monocytes in patients diagnosed with SARS-CoV-2 pneumonia: a mini review of the literature","volume":"25","author":"Lagadinou M","year":"2021","unstructured":"Lagadinou M, Zareifopoulos N, Gkentzi D, Sampsonas F, Kostopoulou E, Marangos M, Solomou E. Alterations in lymphocyte subsets and monocytes in patients diagnosed with SARS-CoV-2 pneumonia: a mini review of the literature. Eur Rev Med Pharmacol Sci. 2021, 25:5057-62. 10.26355\/eurrev_202108_26463","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/JBR.0000000000000089","article-title":"Changes of lymphocyte subsets in patients with COVID-19 and clinical significance: a case-control observation study","volume":"4","author":"Yang G","year":"2021","unstructured":"Yang G, Feng F, Li X, Zhang T, Li X, Li B. Changes of lymphocyte subsets in patients with COVID-19 and clinical significance: a case-control observation study. J Bio-X Res. 2021, 4:36-9. 10.1097\/JBR.0000000000000089","journal-title":"J Bio-X Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa150","article-title":"Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia","volume":"221","author":"Wang F","year":"2020","unstructured":"Wang F, Nie J, Wang H, et al.. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis. 2020, 221:1762-9. 10.1093\/infdis\/jiaa150","journal-title":"J Infect Dis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13276","article-title":"Peripheral lymphocyte subset alterations in COVID-19 patients","volume":"42","author":"Chan SS","year":"2020","unstructured":"Chan SS, Christopher D, Tan GB, Chong VC, Fan BE, Lin CY, Ong KH. Peripheral lymphocyte subset alterations in COVID-19 patients. Int J Lab Hematol. 2020, 42:e199-203. 10.1111\/ijlh.13276","journal-title":"Int J Lab Hematol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa252","article-title":"T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019","volume":"222","author":"Jiang M","year":"2020","unstructured":"Jiang M, Guo Y, Luo Q, et al.. T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019. J Infect Dis. 2020, 222:198-202. 10.1093\/infdis\/jiaa252","journal-title":"J Infect Dis"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.054","article-title":"Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19","volume":"81","author":"Liu Z","year":"2020","unstructured":"Liu Z, Long W, Tu M, et al.. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19. J Infect. 2020, 81:318-56. 10.1016\/j.jinf.2020.03.054","journal-title":"J Infect"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2020.0166","article-title":"Lymphocyte subset alteration and monocyte CD4 expression reduction in patients with severe COVID-19","volume":"34","author":"Kazancioglu S","year":"2021","unstructured":"Kazancioglu S, Yilmaz FM, Bastug A, et al.. Lymphocyte subset alteration and monocyte CD4 expression reduction in patients with severe COVID-19. Viral Immunol. 2021, 34:342-51. 10.1089\/vim.2020.0166","journal-title":"Viral Immunol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen G","year":"2020","unstructured":"Chen G, Wu D, Guo W, et al.. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020, 130:2620-9. 10.1172\/JCI137244","journal-title":"J Clin Invest"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2020.0062","article-title":"Correlation between relative nasopharyngeal virus RNA load and lymphocyte count disease severity in patients with COVID-19","volume":"34","author":"Liu Y","year":"2021","unstructured":"Liu Y, Liao W, Wan L, Xiang T, Zhang W. Correlation between relative nasopharyngeal virus RNA load and lymphocyte count disease severity in patients with COVID-19. Viral Immunol. 2021, 34:330-5. 10.1089\/vim.2020.0062","journal-title":"Viral Immunol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.27.20045427","article-title":"The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes","author":"Chen Y","year":"2020","unstructured":"Chen Y, Feng Z, Diao B, et al.. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes. medRxiv. 2020, 10.1101\/2020.03.27.20045427","journal-title":"medRxiv"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad M","year":"2020","unstructured":"Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020, 20:355-62. 10.1038\/s41577-020-0331-4","journal-title":"Nat Rev Immunol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao B","year":"2020","unstructured":"Diao B, Wang C, Tan Y, et al.. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 2020, 11:827. 10.3389\/fimmu.2020.00827","journal-title":"Front Immunol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.560330","article-title":"Early phases of COVID-19 are characterized by a reduction in lymphocyte populations and the presence of atypical monocytes","volume":"11","author":"Lombardi A","year":"2020","unstructured":"Lombardi A, Trombetta E, Cattaneo A, et al.. Early phases of COVID-19 are characterized by a reduction in lymphocyte populations and the presence of atypical monocytes. Front Immunol. 2020, 11:560330. 10.3389\/fimmu.2020.560330","journal-title":"Front Immunol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis EJ","year":"2020","unstructured":"Giamarellos-Bourboulis EJ, Netea MG, Rovina N, et al.. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020, 27:992-1000.e3. 10.1016\/j.chom.2020.04.009","journal-title":"Cell Host Microbe"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18489","article-title":"Coronavirus disease 2019 (COVID-19): focus on peripheral blood cell morphology","volume":"200","author":"Zini G","year":"2023","unstructured":"Zini G, d'Onofrio G. Coronavirus disease 2019 (COVID-19): focus on peripheral blood cell morphology. Br J Haematol. 2023, 200:404-19. 10.1111\/bjh.18489","journal-title":"Br J Haematol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.4103\/ijh.ijh_30_23","article-title":"Coronavirus disease 2019: morphological changes in peripheral blood cells","volume":"12","author":"Alamin","year":"2023","unstructured":"Alamin, Amin A. Coronavirus disease 2019: morphological changes in peripheral blood cells. Iraqi J Hematol. 2023, 12:1-7. 10.4103\/ijh.ijh_30_23","journal-title":"Iraqi J Hematol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1007\/s12308-021-00459-3","article-title":"Blood cell morphology and COVID-19 clinical course, severity, and outcome","volume":"14","author":"Pezeshki A","year":"2021","unstructured":"Pezeshki A, Vaezi A, Nematollahi P. Blood cell morphology and COVID-19 clinical course, severity, and outcome. J Hematop. 2021, 14:221-8. 10.1007\/s12308-021-00459-3","journal-title":"J Hematop"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13720","article-title":"Changes in peripheral blood in SARS CoV-2 patients and its clinico-pathological correlation: a prospective cross-sectional study","volume":"43","author":"Bahadur S","year":"2021","unstructured":"Bahadur S, Kalonia T, Kamini K, Gupta B, Kalhan S, Jain M. Changes in peripheral blood in SARS CoV-2 patients and its clinico-pathological correlation: a prospective cross-sectional study. Int J Lab Hematol. 2021, 43:1334-40. 10.1111\/ijlh.13720","journal-title":"Int J Lab Hematol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16848","article-title":"Atypical lymphocytes in peripheral blood of patients with COVID-19","volume":"190","author":"Weinberg SE","year":"2020","unstructured":"Weinberg SE, Behdad A, Ji P. Atypical lymphocytes in peripheral blood of patients with COVID-19. Br J Haematol. 2020, 190:36-9. 10.1111\/bjh.16848","journal-title":"Br J Haematol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqaa108","article-title":"Peripheral blood examination findings in SARS-CoV-2 infection","volume":"154","author":"Nazarullah A","year":"2020","unstructured":"Nazarullah A, Liang C, Villarreal A, Higgins RA, Mais DD. Peripheral blood examination findings in SARS-CoV-2 infection. Am J Clin Pathol. 2020, 154:319-29. 10.1093\/ajcp\/aqaa108","journal-title":"Am J Clin Pathol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13416","article-title":"Morphologic changes in circulating blood cells of COVID-19 patients","volume":"13","author":"Kaur G","year":"2021","unstructured":"Kaur G, Sandeep F, Olayinka O, Gupta G. Morphologic changes in circulating blood cells of COVID-19 patients. Cureus. 2021, 13:e13416. 10.7759\/cureus.13416","journal-title":"Cureus"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27793","article-title":"Comparison of hematologic abnormalities between hospitalized coronavirus disease 2019\u00a0positive and negative patients with correlation to disease severity and outcome","volume":"94","author":"Jain S","year":"2022","unstructured":"Jain S, Meena R, Kumar V, Kaur R, Tiwari U. Comparison of hematologic abnormalities between hospitalized coronavirus disease 2019\u00a0positive and negative patients with correlation to disease severity and outcome. J Med Virol. 2022, 94:3757-67. 10.1002\/jmv.27793","journal-title":"J Med Virol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2021.009","article-title":"Peripheral blood smear findings of COVID-19 patients provide information about the severity of the disease and the duration of hospital stay","volume":"13","author":"Berber I","year":"2021","unstructured":"Berber I, Cagasar O, Sarici A, et al.. Peripheral blood smear findings of COVID-19 patients provide information about the severity of the disease and the duration of hospital stay. Mediterr J Hematol Infect Dis. 2021, 13:e2021009. 10.4084\/MJHID.2021.009","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.20-0721","article-title":"Peripheral blood smear demonstration of lymphocyte changes in severe COVID-19","volume":"103","author":"Lee CT","year":"2020","unstructured":"Lee CT, Teo WZ. Peripheral blood smear demonstration of lymphocyte changes in severe COVID-19. Am J Trop Med Hyg. 2020, 103:1350-1. 10.4269\/ajtmh.20-0721","journal-title":"Am J Trop Med Hyg"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006665","article-title":"Morphological changes in a case of SARS-CoV-2 infection","volume":"135","author":"Jones JR","year":"2020","unstructured":"Jones JR, Ireland R. Morphological changes in a case of SARS-CoV-2 infection. Blood. 2020, 135:2324. 10.1182\/blood.2020006665","journal-title":"Blood"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24527","article-title":"Morphological abnormalities of peripheral blood cells among patients with COVID-19 disease","volume":"10","author":"Karapetyan A","year":"2024","unstructured":"Karapetyan A, Niazyan L, Shushanyan R, et al.. Morphological abnormalities of peripheral blood cells among patients with COVID-19 disease. Heliyon. 2024, 10:e24527. 10.1016\/j.heliyon.2024.e24527","journal-title":"Heliyon"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-236117","article-title":"Morphology of COVID-19-affected cells in peripheral blood film","volume":"13","author":"Singh A","year":"2020","unstructured":"Singh A, Sood N, Narang V, Goyal A. Morphology of COVID-19-affected cells in peripheral blood film. BMJ Case Rep. 2020, 13:10.1136\/bcr-2020-236117","journal-title":"BMJ Case Rep"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3390\/hematolrep14030031","article-title":"Hematologic complications in patients hospitalized with COVID-19 infection","volume":"14","author":"Lin E","year":"2022","unstructured":"Lin E, Araj E, Markantonis J, Luu H, Chen M. Hematologic complications in patients hospitalized with COVID-19 infection. Hematol Rep. 2022, 14:228-34. 10.3390\/hematolrep14030031","journal-title":"Hematol Rep"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.galenos.2020.2020.0262","article-title":"Peripheral blood smear findings in COVID-19","volume":"37","author":"Ahnach M","year":"2020","unstructured":"Ahnach M, Ousti F, Nejjari S, Houssaini MS, Dini N. Peripheral blood smear findings in COVID-19. Turk J Haematol. 2020, 37:310-02. 10.4274\/tjh.galenos.2020.2020.0262","journal-title":"Turk J Haematol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.galenos.2020.2020.0342","article-title":"Dysplastic changes of peripheral blood cells in COVID-19 infection","volume":"38","author":"Ak\u00e7abelen YM","year":"2021","unstructured":"Ak\u00e7abelen YM, G\u00fcrlek G\u00f6k\u00e7ebay D, Yaral\u0131 N. Dysplastic changes of peripheral blood cells in COVID-19 infection. Turk J Haematol. 2021, 38:72-3. 10.4274\/tjh.galenos.2020.2020.0342","journal-title":"Turk J Haematol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP3G8MDUXYSCID","article-title":"Understanding and recognizing the Pelger-Hu\u00ebt anomaly","volume":"137","author":"Colella R","year":"2012","unstructured":"Colella R, Hollensead SC. Understanding and recognizing the Pelger-Hu\u00ebt anomaly. Am J Clin Pathol. 2012, 137:358-66. 10.1309\/AJCP3G8MDUXYSCID","journal-title":"Am J Clin Pathol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.932013","article-title":"Red blood cell morphologic abnormalities in patients hospitalized for COVID-19","volume":"13","author":"Marchi G","year":"2022","unstructured":"Marchi G, Bozzini C, Bertolone L, et al.. Red blood cell morphologic abnormalities in patients hospitalized for COVID-19. Front Physiol. 2022, 13:932013. 10.3389\/fphys.2022.932013","journal-title":"Front Physiol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02362-7","article-title":"A case of thrombotic thrombocytopenic purpura associated with COVID-19","volume":"52","author":"Nicolotti D","year":"2021","unstructured":"Nicolotti D, Bignami EG, Rossi S, Vezzani A. A case of thrombotic thrombocytopenic purpura associated with COVID-19. J Thromb Thrombolysis. 2021, 52:468-70. 10.1007\/s11239-020-02362-7","journal-title":"J Thromb Thrombolysis"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2021.05.025","article-title":"Physical phenotype of blood cells is altered in COVID-19","volume":"120","author":"Kub\u00e1nkov\u00e1 M","year":"2021","unstructured":"Kub\u00e1nkov\u00e1 M, Hohberger B, Hoffmanns J, F\u00fcrst J, Herrmann M, Guck J, Kr\u00e4ter M. Physical phenotype of blood cells is altered in COVID-19. Biophys J. 2021, 120:2838-47. 10.1016\/j.bpj.2021.05.025","journal-title":"Biophys J"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1038\/srep04348","article-title":"The plasma protein fibrinogen stabilizes clusters of red blood cells in microcapillary flows","volume":"4","author":"Brust M","year":"2014","unstructured":"Brust M, Aouane O, Thi\u00e9baud M, et al.. The plasma protein fibrinogen stabilizes clusters of red blood cells in microcapillary flows. Sci Rep. 2014, 4:4348. 10.1038\/srep04348","journal-title":"Sci Rep"},{"key":"ref73","article-title":"Peripheral blood smear","author":"Lynch EC:","year":"1990","unstructured":"Lynch EC. : Peripheral blood smear. Clinical Methods: The History, Physical, and Laboratory Examinations. Walker HK, Hall WD, Hurst JW (ed): Butterworths, Boston; 1990."},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.44","article-title":"Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cells","volume":"1","author":"L\u00fcke F","year":"2020","unstructured":"L\u00fcke F, Ors\u00f3 E, Kirsten J, et al.. Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cells. EJHaem. 2020, 1:376-83. 10.1002\/jha2.44","journal-title":"EJHaem"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112902","article-title":"SARS-CoV-2 impact on red blood cell morphology","volume":"11","author":"Kondratov KA","year":"2023","unstructured":"Kondratov KA, Artamonov AA, Mikhailovskii VY, et al.. SARS-CoV-2 impact on red blood cell morphology. Biomedicines. 2023, 11:10.3390\/biomedicines11112902","journal-title":"Biomedicines"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16943","article-title":"Rapid screening of COVID-19 patients using white blood cell scattergrams, a study on 381 patients","volume":"190","author":"Osman J","year":"2020","unstructured":"Osman J, Lambert J, Templ\u00e9 M, et al.. Rapid screening of COVID-19 patients using white blood cell scattergrams, a study on 381 patients. Br J Haematol. 2020, 190:718-22. 10.1111\/bjh.16943","journal-title":"Br J Haematol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2022\/56018.16794","article-title":"Comparative assessment of WBC scattergram, histogram and platelet indices in COVID-19 and non covid-19 patients: a cross-sectional study","volume":"16","author":"Nikhil","year":"2022","unstructured":"Nikhil, Das S, Kalyani R. Comparative assessment of WBC scattergram, histogram and platelet indices in COVID-19 and non covid-19 patients: a cross-sectional study. J Clin Diagn Res. 2022, 16:41-6. 10.7860\/JCDR\/2022\/56018.16794","journal-title":"J Clin Diagn Res"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.850846","article-title":"Definition of the immune parameters related to COVID-19 severity","volume":"13","author":"Birindelli S","year":"2022","unstructured":"Birindelli S, Tarkowski MS, Gallucci M, et al.. Definition of the immune parameters related to COVID-19 severity. Front Immunol. 2022, 13:850846. 10.3389\/fimmu.2022.850846","journal-title":"Front Immunol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-1529","article-title":"Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer","volume":"59","author":"Martens RJ","year":"2021","unstructured":"Martens RJ, van Adrichem AJ, Mattheij NJ, et al.. Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer. Clin Chem Lab Med. 2021, 59:783-93. 10.1515\/cclm-2020-1529","journal-title":"Clin Chem Lab Med"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20150","article-title":"Identification and quantification of high fluorescence-stained lymphocytes as antibody synthesizing\/secreting cells using the automated routine hematology analyzer XE-2100","volume":"72","author":"Linssen J","year":"2007","unstructured":"Linssen J, Jennissen V, Hildmann J, et al.. Identification and quantification of high fluorescence-stained lymphocytes as antibody synthesizing\/secreting cells using the automated routine hematology analyzer XE-2100. Cytometry B Clin Cytom. 2007, 72:157-66. 10.1002\/cyto.b.20150","journal-title":"Cytometry B Clin Cytom"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.21037\/jlpm-22-47","article-title":"Leukocyte differential and cell population data in the evaluation of SARS-CoV-2 and other infections","volume":"8","author":"Urrechaga E","year":"2023","unstructured":"Urrechaga E, Espana PP, Uranga A, Fern\u00e1ndez M, Haider RZ, Garcia de Guadiana L, Aguirre U. Leukocyte differential and cell population data in the evaluation of SARS-CoV-2 and other infections. J Lab Precis Med. 2023, 8:2. 10.21037\/jlpm-22-47","journal-title":"J Lab Precis Med"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.21037\/jlpm-21-26","article-title":"Specific leukocyte differential and morphological alarms a clue for the detection of SARS-CoV-2 infection","volume":"6","author":"Urrechaga E","year":"2021","unstructured":"Urrechaga E, B\u00f3veda O, Hern\u00e1ndez M, et al.. Specific leukocyte differential and morphological alarms a clue for the detection of SARS-CoV-2 infection. J Lab Precis Med. 2021, 6:32. 10.21037\/jlpm-21-26","journal-title":"J Lab Precis Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/328598-a-review-of-the-hematological-picture-of-severe-covid-19-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T07:23:29Z","timestamp":1739172209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/328598-a-review-of-the-hematological-picture-of-severe-covid-19-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,9]]},"references-count":82,"URL":"https:\/\/doi.org\/10.7759\/cureus.78797","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,9]]}}}